NCT06003244View on ClinicalTrials.gov

High Altitude (HA) Residents With Pulmonary Vascular Diseases (PVD), 6 Minute Walk Distance (6MWD) Assessed at 2840m (HA) With and Without Supplemental Oxygen Therapy (SOT)

NAActive, not recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 23, 2023

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Pulmonary Vascular DiseasePulmonary Artery HypertensionChronic Thromboembolic Pulmonary Hypertension
Interventions
OTHER

6-minute walk distance (6MWD) test

6-minute walk distance (6MWD) test will be performed according to clinical standards

OTHER

6-minute walk distance (6MWD) test with supplemental oxygen (3 l/min, nasal)

6-minute walk distance (6MWD) test will be performed according to clinical standards additionally with supplemental oxygen therapy (3l/min, nasal)

Trial Locations (1)

8091

University Hospital Zürich, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER

NCT06003244 - High Altitude (HA) Residents With Pulmonary Vascular Diseases (PVD), 6 Minute Walk Distance (6MWD) Assessed at 2840m (HA) With and Without Supplemental Oxygen Therapy (SOT) | Biotech Hunter | Biotech Hunter